Clinical trial
Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia
NCT00370084 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00370084 |
|---|---|
| Title | Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia |
| Official title | Effects of Itopride Hydrochloride on Gastric Emptying, Glycaemia and "Meal-related" Symptoms in Patients With Type 1 and Type 2 Diabetes Mellitus |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Gastroparesis |
| Intervention type | Drug, Other |
| Interventions | Itopride, Placebo |
| Enrollment | 25 |
| Start date | Mar 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Aug 30, 2006 |
| Last update posted | Feb 9, 2017 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: